DAP10 Integration in CAR-T Cells Enhances the Killing of Heterogeneous Tumors by Harnessing Endogenous NKG2D

The authors designed a DAP10 chimeric receptor that utilized native NKG2D on T cells to target NKG2D ligand-expressing cancer cells.